← SynDRA
SUVECALTAMIDE
SynDRA canonical compound SYN0026415 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CACNA1G |
|---|
| Mechanism of action | T-type calcium channel blocker |
|---|
All known targets
Mechanisms of action (all sources)
- CACNA1H MODULATOR
- Voltage-gated T-type calcium channel modulator
- CACNA1G MODULATOR
- CACNA1I MODULATOR
- CACNA1G INHIBITOR
- CACNA1H INHIBITOR
- CACNA1I INHIBITOR
- T-type calcium channel blocker
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CNR2
- KCNH2
- NEIL1
- TDG
- SMUG1
- SCN5A
- OGG1
- NTHL1
- NR1I2
- NEIL2
- MUTYH
- CYP1A2
- MPG
- CYP3A5
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C8
- CYP2C19
- UNG
Cross-references
Synonyms
- CX-8998
- MK-8998
- JZP-385
- JZP385
- Cx-8998
- Suvecaltamide [USAN]
- MIA4WMP8QN
- MK-8998 free base
- UNII-MIA4WMP8QN
- MK8998
- SUVECALTAMIDE [INN]
- SUVECALTAMIDE [WHO-DD]
- compound 1 [PMID: 27579577]
- compound 1 [PMID: 34582192]
- Suvecaltamide (USAN)
- compound 1 (PMID: 27579577)
- compound 1 (PMID: 34582192)
- RefChem:186857
- MFCD22572346
- orb1301636
- SCHEMBL1065999
- SCHEMBL29791943
- GTPL12648
- GLXC-10813
- DNB77858
- EX-A2479
- BDBM50192668
- WHO 11291
- AKOS032945005
- CS-6198
- AC-35480
- BS-17962
- MK-8998?
- SY250111
- DB-362320
- HY-101096
- T5632
- C77290
- D12061
Look up SUVECALTAMIDE in the interactive SynDRA portal →